Co-pay Relief Assistance for Covid-19

PAF’s Co-Pay Relief Expanded Assistance Through the

COVID-19 Fund to Better Address Patient Needs

Beginning on March 1, 2021, PAF’s Co-Pay Relief (CPR) program expanded its assistance to cover additional expenses incurred by those diagnosed with COVID-19 and increased the grant award to $3000 for new and renewing patients.

In response to identified support needs that exist for patients diagnosed with COVID-19 and who are eligible for support from the COVID-19 fund, CPR will now cover additional expenses including:

• Medical insurance premiums

• Current, new, and renewing patients receiving assistance from the COVID-19 fund can use their award to reimburse for individual health insurance premiums, or to have their insurance premiums paid directly to their insurance provider.

• Over the counter(OTC) medications

• Current, new, and renewing patients receiving assistance from the COVID-19 fund can use their grant for OTC medications, using the Virtual Pharmacy Card to pay at the pharmacy for products to manage the symptoms associated with COVID-19 or submit for reimbursement for OTC medications already purchased.

• Office visit co-payment expenses associated with the diagnosis and/or treatment of COVID-19.

In addition, the COVID-19 grant award has been increased to $3000 for all new or renewal applications received on or after 3/1/2021.

To learn more, or to apply for assistance, please visit https://copays.org/funds/covid-19/ or call our dedicated CPR staff toll-free at 866-512-3861.

The Co-Pay Relief Program may help eligible patients with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition. The program helps patients on a first-come, first-serve basis and processes applicants in the order in which completed applications are received.